{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:53:49Z","timestamp":1760608429727},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2007,6,1]]},"DOI":"10.1532\/ijh97.06214","type":"journal-article","created":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T21:38:59Z","timestamp":1182289139000},"page":"397-402","source":"Crossref","is-referenced-by-count":5,"title":["Factor VIII-Mediated Global Hemostasis in the Absence of von Willebrand Factor"],"prefix":"10.1007","volume":"85","author":[{"given":"Masahiro","family":"Takeyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Kasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Naka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Sadler JE. A revised classification of von Willebrand disease: for the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. <i>Thromb Haemost.<\/i> 1994;71:520-525.","DOI":"10.1055\/s-0038-1642471"},{"key":"E00002","unstructured":"Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. <i>Thromb Haemost.<\/i> 2001;85:958-965."},{"key":"E00003","unstructured":"Mannucci PM, Tamaro G, Narchi G, et al. Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor. <i>Eur J Haematol.<\/i> 1987;39:467-470."},{"key":"E00004","unstructured":"Bergamaschini L, Mannucci PM, Federici AB, Coppola R, Guzzoni S, Agostoni A. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor. <i>J Lab Clin Med.<\/i> 1995;125:348-355."},{"key":"E00005","unstructured":"Boyer-Neumann C, Dreyfus M, Wolf M, Veyradier A, Meyer D. Multi-therapeutic approach to manage delivery in an alloimmunized patient with type 3 von Willebrand disease. <i>J Thromb Haemost.<\/i> 2003;1:190-192."},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Sakurai Y, Shima M, Imai Y, Omura S, Kirita T, Yoshioka A. Successful use of recombinant factor VIII devoid of von Willebrand factor during multiple teeth extractions in a patient with type 3 von Willebrand disease. <i>Blood Coagul Fibrin<\/i>. 2006;17:151-154.","DOI":"10.1097\/01.mbc.0000214711.19116.09"},{"key":"E00007","unstructured":"Noe DA. A mathematical model of coagulation factor VIII kinetics. <i>Haemostasis<\/i>. 1996;26:289-303."},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Vig S, Chitolie A, Bevan DH, Halliday A, Dormandy J. Thromboelastography: a reliable test? <i>Blood Coagul Fibrin<\/i>. 2001;12:555-561.","DOI":"10.1097\/00001721-200110000-00008"},{"key":"E00009","unstructured":"Mikhailidis DP, Barradas MA, Maris A, Jeremy JY, Dandona P. Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease. <i>J Clin Pathol.<\/i> 1985;38:1166-1171."},{"key":"E00010","unstructured":"Ikeda Y, Handa M, Kawano K, et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. <i>J Clin Invest.<\/i> 1991;87:1234-1240."},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Sakurai Y, Fujimura Y, Kokubo T, et al. The cDNA cloning and molecular characterization of a snake venom platelet glycoprotein Ib-binding protein, mamushigin, from <i>Agkistrodon halys blomhoffii<\/i> venom. <i>Thromb Haemost<\/i>. 1998;79:1199-1207.","DOI":"10.1055\/s-0037-1615040"},{"key":"E00012","unstructured":"Pollock WK, Rink TJ. Thrombin and ionomycin can raise platelet cytosolic Ca<sup>2+<\/sup> to micromolar levels by discharge of internal Ca<sup>2+<\/sup> stores: studies using fura-2. <i>Biochem Biophys Res Commun.<\/i> 1986;139:308-314."},{"key":"E00013","unstructured":"Grynkiewicz G, Poenie M, Tsein RY. A new generation of Ca<sup>2+<\/sup> indicators with greatly improved fluorescence properties. <i>J Biol Chem.<\/i> 1985;260:3440-3450."},{"key":"E00014","unstructured":"Kasuda S, Sakurai Y, Shima M, et al. Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro. <i>Alcohol Clin Exp Res.<\/i> 2006;30:1608-1614."},{"key":"E00015","unstructured":"Calatzis A, Haas S, G\u00f6dje O, Calatzis A, Hipp R, Walenga J. Thromboelastographic coagulation monitoring during cardiovascular surgery with the ROTEG coagulation analyzer. In: Pifarr\u00e9 R, ed. <i>Management of Bleeding in Cardiovascular Surgery<\/i>. Philadelphia, Pa: Hanley & Belfus; 2000:215-226."},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"S\u00f8rensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. <i>J Thromb Haemost<\/i>. 2003;1:551-558.","DOI":"10.1046\/j.1538-7836.2003.00075.x"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Sambrano GR, Weiss EJ, Zheng YW, Huang W, Coughlin SR. Role of thrombin signalling in platelets in haemostasis and thrombosis. <i>Nature<\/i>. 2001;413:74-78.","DOI":"10.1038\/35092573"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. <i>Thromb Haemost<\/i>. 2002;88:186-193.","DOI":"10.1055\/s-0037-1613209"},{"key":"E00019","unstructured":"Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. <i>Cell.<\/i> 1996;84:289-297."},{"key":"E00020","unstructured":"Berndt MC, Gregory C, Dowden G, Castaldi PA. Thrombin interactions with platelet membrane proteins. <i>Ann N Y Acad Sci.<\/i> 1986;485:374-386."},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Yoshioka A, Peake IR, Furlong BL, Furlong RA, Giddings JC, Bloom AL. The interaction between factor VIII clotting antigen (VIIICAg) and phospholipid. <i>Br J Haematol<\/i>. 1983;55:27-36.","DOI":"10.1111\/j.1365-2141.1983.tb01221.x"},{"key":"E00022","unstructured":"Muntean W, Leschnik B, Haas J. Factor VIII coagulant moiety binds to platelets by binding to phospholipids of the platelet membrane. <i>Thromb Res.<\/i> 1987;45:345-354."},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Kahn ML, Zheng YW, Huang W, et al. A dual thrombin receptor system for platelet activation. <i>Nature<\/i>. 1998;394:690-694.","DOI":"10.1038\/29325"},{"key":"E00024","unstructured":"Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. <i>J Clin Invest.<\/i> 1999;103:879-887."},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Covic L, Gresser AL, Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. <i>Biochemistry<\/i>. 2000;39:5458-5467.","DOI":"10.1021\/bi9927078"},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Federici AB, Mannucci PM. Optimizing therapy with factor VIII\/von Willebrand factor concentrates in von Willebrand disease. <i>Haemophilia<\/i>. 1998;4(suppl 3):7-10.","DOI":"10.1046\/j.1365-2516.1998.0040s3007.x"},{"key":"E00027","unstructured":"Castaman G, Federici AB, Rodeghiero F, Mannucci PM. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. <i>Haematologica<\/i>. 2003;88:94-108."}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.06214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T05:25:02Z","timestamp":1556515502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.06214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,6,1]]}},"alternative-id":["2WVJ80461MP70163"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.06214","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}